AC Immune (ACIU) Depreciation and Depletion (2015 - 2025)

AC Immune (ACIU) has 11 years of Depreciation and Depletion data on file, last reported at $411634.9 in Q4 2025.

• Quarterly Depreciation and Depletion changed 0.45% year-over-year to $411634.9 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.7 million (down 0.66% YoY) and the FY2025 annual result came in at $1.7 million, down 0.89% from the prior year.
• Depreciation and Depletion declined to $411634.9 in Q4 2025 per ACIU's latest filing, from $425037.2 in the prior quarter.
• Across five years, Depreciation and Depletion topped out at $539118.9 in Q3 2021 and bottomed at $401522.4 in Q1 2025.
• The 5-year median for Depreciation and Depletion is $452536.6 (2022), against an average of $459036.8.
• The widest annual swing landed in 2021, when Depreciation and Depletion soared 37.14%; it then decreased 15.88% in 2022.
• Tracing ACIU's Depreciation and Depletion over 5 years: stood at $527068.0 in 2021, then dropped by 9.01% to $479566.1 in 2022, then slipped by 1.97% to $470106.8 in 2023, then dropped by 12.83% to $409806.3 in 2024, then rose by 0.45% to $411634.9 in 2025.
• Per Business Quant, the three latest ACIU Depreciation and Depletion figures stand at $411634.9 (Q4 2025), $425037.2 (Q3 2025), and $438464.2 (Q2 2025).

Peer Comparison